The beneficial effects of neuraminidase inhibitor drug therapy on severe patient outcomes during the 2009-2010 influenza A virus subtype H1N1 pandemic.

摘要

Elsewhere in the pages of the Journal, Muthuri et al answer a question of substantial contemporary importance to clinicians and public health decision makers, namely, whether antiviral therapy for influenza can reduce severe outcomes of the disease in hospitalized patients [1].